P733: TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES RECEIVING LUSPATERCEPT IN ROUTINE CLINICAL PRACTICE IN THE UNITED STATES by Sudipto Mukherjee, Cherrishe Brown-Bickerstaff, David Huggar, Angelica Falkenstein, Adeola Y. Makinde, Emily Bland, Jalyna Laney, Marné Garretson, Ali Mcbride

Get full text

Treatment patterns and outcomes with luspatercept in patients with lower‐risk myelodysplastic syndromes: A retrospective US cohort analysis by Sudipto Mukherjee, Cherrishe Brown‐Bickerstaff, Angelica Falkenstein, Adeola Y. Makinde, Emily Bland, JaLyna Laney, Marné Garretson, David Huggar, Ali McBride

Get full text

P515: A REAL-WORLD EVALUATION OF TREATMENT PATTERNS AND OUTCOMES OF ACUTE MYELOID LEUKEMIA INDUCTION THERAPIES IN THE COMMUNITY SETTING by Keri Maher, Cherrishe Brown-Bickerstaff, Ying Qiu, Ali Mcbride, Djibril Liassou, Jalyna Laney, Marné Garretson, David Huggar, Ajeet Gajra, Jiafan Chen, David Hughes

Get full text

Real-world clinical outcomes and rationale for initiating abatacept as a first-line biologic for patients with anticitrullinated protein antibody- and rheumatoid factor-positive rh... by Alexandrina Balanean, Cherrishe Brown-Bickerstaff, Andrew Klink, Vardhaman Patel, Hanke Zheng, Laetitia N’Dri, Keith Wittstock, Bruce Feinberg, Mark Chaballa, Vadim Khaychuk, Jill Kaufman, Prathamesh Pathak, Gordon Lam